News | June 21, 2021
Zydus and Bayer announce extension of their JV
Bayer Zydus Pharma will continue to operate in core therapies with new products in the pipeline
Bayer Zydus Pharma will continue to operate in core therapies with new products in the pipeline
India is expecting to manufacture 30-35 crore COVID-19 vaccines between July - August 2021
Broadens company’s oncology platform of Targeted Alpha Therapies (TATs)
The Banzel Tablets, 200 mg and 400 mg market2 achieved annual sales of approximately $285.3 million.
Aurobindo has one of the most enduring generics ecosystems among peers
Cadila's ZyCov-D (DNA-based vaccine) is undergoing phase III trials.
The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19
We focused on developing the product last year but now our focus is on ramping up our manufacturing capacity
The product patent has been already filed under fast track approval
This test is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in the upper and lower respiratory specimens from individuals suspected of COVID-19
Subscribe To Our Newsletter & Stay Updated
